Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.

Joseph MM, Aravind SR, George SK, Pillai RK, Mini S, Sreelekha TT.

Transl Oncol. 2014 Oct 24;7(5):525-36. doi: 10.1016/j.tranon.2014.07.003. eCollection 2014 Oct.

PMID:
25389448
[PubMed]
Free PMC Article
2.

Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM.

Kesavadev J, Sadikot S, Wangnoo S, Kannampilly J, Saboo B, Aravind SR, Kalra S, Makkar BM, Maji D, Saikia M, Anjana RM, Rajput R, Singh SK, Shah S, Dhruv U, Vishwanathan V.

Diabetes Metab Syndr. 2014 Jul-Sep;8(3):187-95. doi: 10.1016/j.dsx.2014.04.030. Epub 2014 May 28.

PMID:
25200925
[PubMed - in process]
3.

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort.

Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, Aravind SR, Sheu W, Nguyen TK, Ozaki R, Deerochanawong C, Tsang CC, Chan WB, Hong EG, Do TQ, Cheung Y, Brown N, Goh SY, Ma RC, Mukhopadhyay M, Ojha AK, Chakraborty S, Kong AP, Lau W, Jia W, Li W, Guo X, Bian R, Weng J, Ji L, Rosa MR, Toledo RM, Himathongkam T, Yoo SJ, Chow CC, Ho LL, Chuang LM, Tutino G, Tong PC, So WY, Wolthers T, Ko G, Lyubomirsky G, Chan JC.

Lancet Diabetes Endocrinol. 2014 Dec;2(12):935-43. doi: 10.1016/S2213-8587(14)70137-8. Epub 2014 Jul 28.

PMID:
25081582
[PubMed - in process]
4.

Weight adds weight to declining quality of life in diabetes.

Aravind SR, Deshpande N.

Curr Med Res Opin. 2014 Jul;30(7):1275-8. doi: 10.1185/03007995.2014.901944. Epub 2014 Mar 26. No abstract available.

PMID:
24597862
[PubMed - in process]
5.

Adding a DPP-4 inhibitor to metformin therapy may be safer than you think.

Aravind SR.

Curr Med Res Opin. 2014 May;30(5):791-4. doi: 10.1185/03007995.2014.893867. Epub 2014 Feb 24. No abstract available.

PMID:
24517395
[PubMed - indexed for MEDLINE]
6.

Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.

Joseph MM, Aravind SR, George SK, Pillai KR, Mini S, Sreelekha TT.

Colloids Surf B Biointerfaces. 2014 Apr 1;116:219-27. doi: 10.1016/j.colsurfb.2013.12.058. Epub 2014 Jan 9.

PMID:
24486833
[PubMed - in process]
7.

A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity.

Joseph MM, Aravind SR, George SK, Varghese S, Sreelekha TT.

Carbohydr Polym. 2013 Nov 6;98(2):1466-75. doi: 10.1016/j.carbpol.2013.07.023. Epub 2013 Jul 17.

PMID:
24053828
[PubMed - indexed for MEDLINE]
8.

PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties.

Joseph MM, Aravind SR, Varghese S, Mini S, Sreelekha TT.

Colloids Surf B Biointerfaces. 2013 Apr 1;104:32-9. doi: 10.1016/j.colsurfb.2012.11.046. Epub 2012 Dec 17.

PMID:
23298585
[PubMed - indexed for MEDLINE]
9.

Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.

Aravind SR, Ismail SB, Balamurugan R, Gupta JB, Wadhwa T, Loh SM, Suryawanshi S, Davies MJ, Girman CJ, Katzeff HL, Radican L, Engel SS, Wolthers T.

Curr Med Res Opin. 2012 Aug;28(8):1289-96. doi: 10.1185/03007995.2012.707119. Epub 2012 Jul 6.

PMID:
22738801
[PubMed - indexed for MEDLINE]
10.

Antitumor and immunopotentiating activity of polysaccharide PST001 isolated from the seed kernel of Tamarindus indica: an in vivo study in mice.

Aravind SR, Joseph MM, Varghese S, Balaram P, Sreelekha TT.

ScientificWorldJournal. 2012;2012:361382. doi: 10.1100/2012/361382. Epub 2012 Apr 19.

PMID:
22593679
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum.

Joseph MM, Aravind SR, Varghese S, Mini S, Sreelekha TT.

Mol Med Rep. 2012 Feb;5(2):489-96. doi: 10.3892/mmr.2011.638. Epub 2011 Oct 18.

PMID:
22012001
[PubMed - indexed for MEDLINE]
12.

Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study.

Aravind SR, Al Tayeb K, Ismail SB, Shehadeh N, Kaddaha G, Liu R, Balshaw R, Lesnikova N, Heisel O, Girman CJ, Musser BJ, Davies MJ, Katzeff HL, Engel SS, Radican L; 2009 Ramadan Study Group.

Curr Med Res Opin. 2011 Jun;27(6):1237-42. doi: 10.1185/03007995.2011.578245. Epub 2011 Apr 20.

PMID:
21506631
[PubMed - indexed for MEDLINE]
13.

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.

DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators, Gerstein HC, Mohan V, Avezum A, Bergenstal RM, Chiasson JL, Garrido M, MacKinnon I, Rao PV, Zinman B, Jung H, Joldersma L, Bosch J, Yusuf S.

Diabetologia. 2011 Mar;54(3):487-95. doi: 10.1007/s00125-010-1985-4. Epub 2010 Nov 30.

PMID:
21116607
[PubMed - indexed for MEDLINE]
14.

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.

Jadzinsky M, Pfützner A, Paz-Pacheco E, Xu Z, Allen E, Chen R; CV181-039 Investigators.

Diabetes Obes Metab. 2009 Jun;11(6):611-22. doi: 10.1111/j.1463-1326.2009.01056.x.

PMID:
19515181
[PubMed - indexed for MEDLINE]
15.

Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995-2008.

Kumar P, Krishna P, Reddy SC, Gurappa M, Aravind SR, Munichoodappa C.

J Indian Med Assoc. 2008 Nov;106(11):708-11.

PMID:
19368094
[PubMed - indexed for MEDLINE]
16.

Barriers to changing dietary behavior.

Kapur K, Kapur A, Ramachandran S, Mohan V, Aravind SR, Badgandi M, Srishyla MV.

J Assoc Physicians India. 2008 Jan;56:27-32.

PMID:
18472496
[PubMed - indexed for MEDLINE]
17.

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S.

Diabetes Care. 2008 May;31(5):1007-14. doi: 10.2337/dc07-1868. Epub 2008 Feb 11.

PMID:
18268075
[PubMed - indexed for MEDLINE]
18.

Allergy to insulin.

Aravind SR.

J Assoc Physicians India. 1995 Nov;43(11):809. No abstract available.

PMID:
8773050
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk